Načítá se...
Molecular control of pathogenic Th17 cells in autoimmune diseases
IL-17A-producing CD4(+) T helper cells (Th17) are crucial for the development of inflammatory and autoimmune diseases and thus are exploited for clinical immunotherapies. Emerging evidence suggests Th17 cells are heterogeneous and able to adopt both pathogenic and non-pathogenic phenotypes which are...
Uloženo v:
| Vydáno v: | Int Immunopharmacol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7031035/ https://ncbi.nlm.nih.gov/pubmed/31931372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.106187 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|